Delphi sells peptides in credits rather than dollars, so no peptide on its menu has a price — and it claims third-party batch testing twice while publishing no certificate a reader could open.
What Delphi Wellness charges
Delphi Wellness does not publish a price today.
Delphi Wellness also sells 5 compounds this site boards without publishing a price for them: Sermorelin, Ipamorelin (board ranks no provider), CJC-1295 (board ranks no provider), BPC-157 (board ranks no provider) and TB-500 (board ranks no provider).
Delphi Wellness is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
A currency, not a price list
The tiers on this page buy monthly credit allowances, and different peptides cost different numbers of credits. The seller says why: credit costs track wholesale price.
That is an internally coherent model and it is completely opaque from outside. No credit cost is published for any peptide, so the allowance cannot be converted into a quantity of anything.
The page contains exactly two dollar amounts. One is a monthly top-up for extra credits, and the other is a valuation gloss on what a tier's allowance is roughly worth. Neither is the price of a peptide, and recording either as one would be fabrication.
Testing claimed twice, published never
The page states that every batch undergoes third-party testing for purity, potency and sterility, and restates it a second time with the same three properties named.
A sweep of every attribute on that page — not just links, but every attribute value, because certificates in this market hide on buttons and image elements — returned nothing matching a certificate, a PDF or an analysis document.
That makes this a claimed-but-unreachable testing row. It is not the same as no claim, and it is not the same as a certificate. This site records the claim and its unreachability as two separate facts, because they point in different directions.
The entity is real and the sentence proves it
A doing-business-as relationship is published in full: the brand is named as a DBA of a limited liability company formed in a named state, and the footer repeats the relationship in different words.
This is the shape that usually turns out to be a false positive on this market — a corporate name in a page footer that belongs to an arbitration body, a payments processor or a web agency. Here the surrounding sentence confirms it is the seller's own.
A named Medical Director appears on the service page. No dispensing pharmacy is named; they are described as licensed and regulated compounders. No state coverage is published.
Who it's for
Readers who want to see what a testing claim looks like when nothing sits behind it.
Buyers comfortable with an allowance model rather than per-item pricing.
Anyone who wants the corporate entity and its state of formation published.
Shoppers who want a named Medical Director.
Who should look elsewhere
Anyone who needs a price for a peptide.
Readers who want a certificate they can open.
Buyers who need the dispensing pharmacy named.
Shoppers who need to know whether the service reaches their state.
Strengths
Names the corporate entity, its state of formation and the DBA relationship in one sentence
Names its Medical Director on the service page
Explains why its credit costs vary rather than leaving the mechanism unstated
Says which pharmacies fill orders by licence class and says peptides ship from them directly
Trade-offs
No peptide on the menu has a dollar price — the unit is a credit, and credit costs are not published
Claims third-party batch testing twice and publishes no certificate, no PDF and no link
The only two figures on the service page are a credit top-up and a valuation gloss
Publishes no state coverage and names no dispensing pharmacy
How we verified this
Fetched the peptide service page and the terms with a full browser user-agent, comparing the effective URL to the requested one on both.
Fired a nonsense-path control at the host in the same run; it returned an honest not-found status.
Joined the text nodes before matching and read both dollar amounts on the service page with the sentences around them.
Established that neither figure prices a peptide, and recorded no price rather than attributing one.
Swept every attribute on the service page — not only links — for a certificate, a PDF or an analysis document, and found none.
Read the doing-business-as sentence in full to confirm the corporate name belongs to the seller rather than to a third party.
Screened the brand and the corporate entity against the regulator's live warning-letter index, with a known-positive and a nonsense control in the same run.
A provider to compare Delphi Wellness against
Auren Rx
Auren Rx names both its prescribing group, Wasef Health, and its dispensing pharmacy, VialsRX in Houston, with street addresses and phone numbers, and lets a subscriber pause an auto-refill plan on NAD+, sermorelin, glutathione or GHK-Cu instead of forcing a full cancellation.